Browse the corpus

REFERENCES Physician Insurers Association of America. Breast cancer study, 3rd edition, Physician Insurers Association of America, Rockville 2002. file://www.neomatrix.com/pdfs/PIAAStudy.pdf (Accessed on January 11, 2012). Singh H, Sethi S, Raber M, Petersen LA. Errors in cancer diagnosis: current understanding and future directions. J Clin Oncol 2007; 25:5009. Gandhi TK, Kachalia A, Thomas EJ, et al. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med 2006; 145:488. Mitnick JS, Vazquez MF, Kronovet SZ, Roses DF. Malpractice litigation involving patients with carcinoma of the breast. J Am Coll Surg 1995; 181:315. Kern KA. Causes of breast cancer malpractice litigation. A 20-year civil court review. Arch Surg 1992; 127:542. Donegan, WL. Diagnosis. In: Cancer of the breast, Donegan, WL, Spratt, JS (Eds), WB Saunders, Philadelphia 1995. p.157. Morrow M. The evaluation of common breast problems. Am Fam Physician 2000; 61:2371. Cady, B, Steele, GD, Morrow, M, et al. Evaluation of Common Breast Problems: A Primer for Primary Care Providers; prepared by the Society of Surgical Oncology and the Commission on Cancer of the American College of Surgeons for the Centers for Disease Control and Prevention, Publication no. 633-001/20900, US Department of Health and Human Services, 1998. www.utmb.edu/Surgery/clerks/primer.htm (Accessed on August 08, 2008). Santen RJ, Mansel R. Benign breast disorders. N Engl J Med 2005; 353:275. Ozanne EM, Klemp JR, Esserman LJ. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J 2006; 12:103. Morrow M. Identification of the woman at risk for breast cancer: problem solved? Recent Results Cancer Res 1999; 151:85. Kauff ND, Brogi E, Scheuer L, et al. Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations. Cancer 2003; 97:1601. Nusbaum, R, Vogel, KJ, Ready, K. Susceptibility to breast cancer: hereditary syndromes and low penetrance genes. Breast Dis 2006-2007; 27:21. Rohan TE, Miller AB. Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Cancer Prev 1999; 8:123. Rohan TE, Negassa A, Chlebowski RT, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst 2008; 100:563.

Rohan TE, Miller AB. Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Cancer Prev 1999; 8:123. Rohan TE, Negassa A, Chlebowski RT, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst 2008; 100:563. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286:2143. Michels KB, Mohllajee AP, Roset-Bahmanyar E, et al. Diet and breast cancer: a review of the prospective observational studies. Cancer 2007; 109:2712. Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 2008; 99:1369. Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008; 10:201. Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet 1995; 346:883. Euhus DM. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 2001; 7:224. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994; 73:643. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23:1111. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 1999; 282:1270. Morrow, M. Physical examination of the breast. In: Breast diseases, 3rd edition, Harris, JR, et al (Eds), Lippincott, Williams, and Wilkins, Philadelphia 2004. p.29. Saunders KJ, Pilgrim CA, Pennypacker HS. Increased proficiency of search in breast self-examination. Cancer 1986; 58:2531. Hall DC, Goldstein MK, Stein GH. Progress in manual breast examination. Cancer 1977; 40:364. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338:1089.

Saunders KJ, Pilgrim CA, Pennypacker HS. Increased proficiency of search in breast self-examination. Cancer 1986; 58:2531. Hall DC, Goldstein MK, Stein GH. Progress in manual breast examination. Cancer 1977; 40:364. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338:1089. Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med 1999; 130:651. Morrow M, Wong S, Venta L. The evaluation of breast masses in women younger than forty years of age. Surgery 1998; 124:634. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ 1998; 158 Suppl 3:S3. Venet L, Strax P, Venet W, Shapiro S. Adequacies and inadequacies of breast examinations by physicians in mass screening. Cancer 1971; 28:1546. Rimsten A, Stenkvist B, Johanson H, Lindgren A. The diagnostic accuracy of palpation and fine-needle biopsy and an evaluation of their combined use in the diagnosis of breast lesions: report on a prospective study in 1244 women with symptoms. Ann Surg 1975; 182:1. van Dam PA, Van Goethem ML, Kersschot E, et al. Palpable solid breast masses: retrospective single- and multimodality evaluation of 201 lesions. Radiology 1988; 166:435. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005; 353:1773. Barlow WE, Lehman CD, Zheng Y, et al. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst 2002; 94:1151. Cahill CJ, Boulter PS, Gibbs NM, Price JL. Features of mammorgraphically negative breast tumours. Br J Surg 1981; 68:882. Donegan WL. Evaluation of a palpable breast mass. N Engl J Med 1992; 327:937. Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol 2008; 26:703. Clarke D, Sudhakaran N, Gateley CA. Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer. Ann R Coll Surg Engl 2001; 83:110.

Donegan WL. Evaluation of a palpable breast mass. N Engl J Med 1992; 327:937. Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol 2008; 26:703. Clarke D, Sudhakaran N, Gateley CA. Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer. Ann R Coll Surg Engl 2001; 83:110. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999; 353:1119. Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999; 353:1132. Coates AS. Breast cancer: delays, dilemmas, and delusions. Lancet 1999; 353:1112. Preece PE, Baum M, Mansel RE, et al. Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) 1982; 284:1299. BeLieu RM. Mastodynia. Obstet Gynecol Clin North Am 1994; 21:461. Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79:353. Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Engl J Med 1982; 307:1010. Devitt JE. Abandoning fibrocystic disease of the breast: timely end of an era. CMAJ 1986; 134:217. Hutter RV. Goodbye to "fibrocystic disease". N Engl J Med 1985; 312:179. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312:146. Hughes LE, Mansel RE, Webster DJ. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987; 2:1316. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985; 55:2698. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992; 23:1095. Leis HP Jr, Greene FL, Cammarata A, Hilfer SE. Nipple discharge: surgical significance. South Med J 1988; 81:20. Da Costa D, Taddese A, Cure ML, et al. Common and unusual diseases of the nipple-areolar complex. Radiographics 2007; 27 Suppl 1:S65. Thiers BH. Dermatologic manifestations of internal cancer. CA Cancer J Clin 1986; 36:130. Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 2002; 40:409.

Da Costa D, Taddese A, Cure ML, et al. Common and unusual diseases of the nipple-areolar complex. Radiographics 2007; 27 Suppl 1:S65. Thiers BH. Dermatologic manifestations of internal cancer. CA Cancer J Clin 1986; 36:130. Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 2002; 40:409. Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med 2003; 139:274. Fajardo LL, Pisano ED, Caudry DJ, et al. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol 2004; 11:293. Topic 804 Version 12.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-118.195.65.248-FDF33D9AD5-S244013.14]